[Prognosis of acute lymphoblastic leukemia, developing isolated testicular involvement at late relapse]. 1984

S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013736 Testicular Neoplasms Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms. Cancer of Testis,Cancer of the Testes,Testicular Cancer,Testicular Neoplasm,Testicular Tumor,Testis Cancer,Cancer of the Testis,Neoplasms, Testicular,Neoplasms, Testis,Testicular Tumors,Testis Neoplasms,Tumor of Rete Testis,Cancer, Testicular,Cancer, Testis,Cancers, Testicular,Cancers, Testis,Neoplasm, Testicular,Neoplasm, Testis,Rete Testis Tumor,Rete Testis Tumors,Testicular Cancers,Testis Cancers,Testis Neoplasm,Testis Tumor, Rete,Testis Tumors, Rete,Tumor, Testicular,Tumors, Testicular

Related Publications

S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
September 2023, Urology case reports,
S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
April 1980, La Nouvelle presse medicale,
S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
August 1990, Journal of reproductive immunology,
S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
June 1993, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
May 1982, Minerva pediatrica,
S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
June 1982, Clinical pediatrics,
S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
June 2010, Pediatrics international : official journal of the Japan Pediatric Society,
S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
January 1999, Indian journal of pediatrics,
S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
March 2010, Journal of pediatric hematology/oncology,
S Arakawa, and S Imashuku, and T Nagai, and Y Morioka, and S Todo, and H Ikuta, and H Izumi, and F Fujiwara, and K Konishi
January 1992, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
Copied contents to your clipboard!